Is Ascendis Pharma A/S (ASND) A Good Stock To Buy?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Ascendis Pharma A/s (ASND)
Get Email Alerts Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | RA Capital Management Peter Kolchinsky | 6,806,341 | $895,374 | +7% | 14.37% |
| 2. | Baker Bros. Advisors Julian Baker And Felix Baker | 3,540,270 | $465,723 | 2.04% | |
| 3. | VenBio Select Advisor Kurt Von Emster | 1,900,000 | $249,945 | 4.34% | |
| 4. | Vivo Capital Albert Cha And Frank Kung | 1,526,359 | $200,793 | -9% | 8.69% |
| 5. | Lone Pine Capital Stephen Mandel | 1,436,981 | $189,035 | 0.59% |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 73,440 | $9,661,033 | 0.09% | |
| 2. | 6,429,407 | $845,789 | 1% | |
| 3. | 5,382,937 | $708,125 | 0.05% | |
| 4. | 5,061,254 | $665,808 | 0.06% | |
| 5. | 3,434,273 | $451,780 | 0.07% |
News See All
Should You Consider Investing in Ascendis Pharma (ASND)?
Artisan Partners, a high value-added investment management firm, published its ‘Artisan Mid Cap Fund’ first quarter 2021 investor letter – a copy of which can be downloaded here.
Is ASND Stock A Buy or Sell?
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 900 active prominent money managers and analyze their...
Free Stock Pick From Insider Monkey’s Monthly Newsletter
Our premium monthly newsletter costs $449 annually and features my personal stock picks.
Is Ascendis Pharma A/S (ASND) Going to Burn These Hedge Funds?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Why Ascendis Pharma (ASND) Stock is a Compelling Investment Case
Brown Advisory recently released its Q2 2020 Investor Letter, a copy of which you can download here.
Did Hedge Funds Make The Right Call On Ascendis Pharma A/S (ASND) ?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Should You Avoid Ascendis Pharma A/S (ASND)?
In this article we will check out the progression of hedge fund sentiment towards Ascendis Pharma A/S (NASDAQ:ASND) and determine whether it is a good investment right now.
Hedge Funds Have Never Been This Bullish On Ascendis Pharma A/S (ASND)
We hate to say this but, we told you so.
How Did Ascendis Pharma A/S (ASND) Compare Against Hedge Fund Darlings in 2019?
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns.
Billionaire Hedge Funds
